In Vitro and in Silico Evaluation of the Potential for Neuroprotection of RhodioLife, a Rhodiola Rosea Roots Extract
José M. Zubeldia, Aarón Hernández-Santana, Miguel Jiménez del Río, Verónica Pérez‐López
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Rhodiola rosea, an adaptogen plant from cold regions, has been previously proposed for alleviating dementia and other neurodegenerative diseases. The goal of our study was to evaluate if our proprietary extract (RhodioLife) was able to elicit biological responses related to neuroprotection in neuronal cultures. NS20Y cells were cultured according to procedures and increasing concentrations of RhodioLife were added to the media. Viability at 24h using Presto Blue TM showed no statistically significant differences at those concentrations (0-50 ppm). Quantitative real-time RT-PCR analysis (G-coupled protein receptor [GCPR] array) showed statistically significant (p<0.05) upregulation of 3 genes: calcitonin receptor-like (CALCRL), cyclin-dependent kinase inhibitor 1A (CDKN1A), and lysophosphatidic acid receptor 2 (LPAR2) (4, 3 and 2-fold respectively). In silico evaluation of the bioactives contained in RhodioLife ( www.molinspiration.com ) revealed that Salidroside, Rosarin, Rosavin, Rosiridin, Cinnamyl alcohol and p-Tyrosol all had 1 or no violations of the Lipinski´s rule of five, suggesting favorable pharmacokinetics. The predicted G-coupled protein receptor bioactivity was greatest for Rosarin (0.39) and Salidroside (0.35). We conclude that RhodioLife contained substances which had relevant biological activity and molecular properties suggesting a role in neuroprotection. Studies in suitable animal models are recommended.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Medicinal Plants and Bioactive Compounds
Medicinal Plants and Neuroprotection · Alzheimer's disease research and treatments
参考文献 31
此处列出前 3 条